Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. Tempus is a technology ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has completed its acquisition of Ambry Genetics ...

Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus Tempus is a ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of its TrailBlazer™ Tag and TrailBlazer StarBright™ Dye Label Kits. The new kits offer a convenient method to label any antibody ...

The new kits offer a convenient method to label any antibody with one of Bio-Rad’s StarBright Dyes, for use in either flow cytometry or fluorescent western blot experiments. The new two-kit ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of its TrailBlazer™ Tag and TrailBlazer ...

Feb. 13, 2025 — New research has revealed that birds, reptiles, and mammals have developed complex brain circuits independently, despite sharing a common ancestor. These findings challenge the ...

Farmers are already dealing with the effects of climate change and avian flu outbreaks, but the Trump administration’s recent efforts to dismantle the U.S. Agency for International Development ...

The global virology specimen collection market, valued at USD 5.6 billion in 2021, is anticipated to experience a slight decline at a negative CAGR of -0.5% during the forecast period from 2022 to ...